Leap Therapeutics closes $58.9M private placement led by Winklevoss Capital to pursue digital asset treasury

CYPHERPUNK TECHNOLOGIES INC.

Gross proceeds of ~$58.88M from sale of 15.2M shares, 80.8M pre-funded warrants, and 72.0M common warrants.
Winklevoss Capital leads the deal; gets right to nominate two board members, one of whom will serve as chair.
Proceeds to fund a digital asset treasury strategy and continue development of FL-501 and sirexatamab.
Common warrants priced at $0.5335/share, 10-year term; pre-funded warrants exercisable at $0.001/share with no expiration.
Parcrest serves as placement agent; receives $1.5M fee ($1M cash plus warrants for 4M shares).

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

CYPHERPUNK TECHNOLOGIES INC. issued up to an aggregate of 80,768,504 shares of Common Stock of warrant to investors named therein for offering price of $0.51964 per Pre-Funded Warrant.

Security: warrant
Shares: up to an aggregate of 80,768,504 shares of Common Stock
Purchaser: investors named therein
Consideration: offering price of $0.51964 per Pre-Funded Warrant

Exact text from the filing

”) of (i) an aggregate of 15,212,311 shares (the “ Shares ”) of common stock of the Company, par value $0.001 per share (the “ Common Stock ”), at an offering price of $0.52064 per share, (ii) pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase up to an aggregate of 80,768,504 shares of Common Stock (the “ Pre-Funded Warrant Shares ”) at an

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

CYPHERPUNK TECHNOLOGIES INC. issued 15,212,311 shares of common stock to investors named therein for $0.52064 per share.

Security: common stock
Shares: 15,212,311 shares
Purchaser: investors named therein
Consideration: $0.52064 per share

Exact text from the filing

”) of (i) an aggregate of 15,212,311 shares (the “ Shares ”) of common stock of the Company, par value $0.001 per share (the “ Common Stock ”), at an offering price of $0.52064 per share, (ii) pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase up to an aggregate of 80,768,504 shares of Common Stock (the “ Pre-Funded Warrant Shares ”) at an

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

CYPHERPUNK TECHNOLOGIES INC. issued up to an aggregate of 71,985,605 shares of Common Stock of warrant to investors named therein for exercise price of $0.5335 per Common Warrant Share.

Security: warrant
Shares: up to an aggregate of 71,985,605 shares of Common Stock
Purchaser: investors named therein
Consideration: exercise price of $0.5335 per Common Warrant Share

Exact text from the filing

”) to purchase up to an aggregate of 71,985,605 shares of Common Stock (the “ Common Warrant Shares ”), each exercisable for one share of Common Stock at the exercise price of $0.5335 per Common Warrant Share. The Private Placement closed on October 8, 2025 (the “ Closing Date ”). The aggregate gross proceeds of the Private Placement were approximately USD

View on SEC.gov

29 equity issuances filed in the last 30 days. Browse all equity issuances →

CYPHERPUNK TECHNOLOGIES INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-098082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.